New call-to-action


See all



Ramsay Health Care – Sell Off But Fundamentals Remain Unchanged

Jordan Baird

Jordan Baird is the head ASR Wealth Advisers client services desk and has been with the organisation since 2017. He first started investing in his early years. While he believes that investors should leave no stone unturned he has a particular interest in trading based on broad macroeconomic trends along with specific analysis of innovative up-and-coming companies.

Ramsay Health Care Ltd (ASX: RHC) is a global health care company mainly operating private hospitals. Ramsay health care has 480 facilities across 11 countries, which makes them one of the largest health care companies globally. Ramsay’s main markets are Australia, the United Kingdom and France. Its market capitalisation is $13.1 billion.

Ramsay Health Care Ltd  - Report

What is the news today?

Today (Tuesday 17 September 2019), Paul Ramsay Holdings Pty Ltd (known as the Paul Ramsay Foundation) sold 22 million ordinary shares in Ramsay Health Care to institutional investors at $61.80 per share.

Following this sale, Paul Ramsay Holdings Pty Ltd will continue to hold approximately 21 per cent of the issued share capital in Ramsay Health Care. The Paul Ramsay Foundation indicated that it has no intention to sell any further Ramsay Health Care shares over the medium to long term and does not possess any information that could materially impact on the price of Ramsay Health Care shares.

What is the market’s reaction?

Ramsey Health Care shares are trading at $61.80, down around 5 per cent following the announcement of the sale.

The important point is that there has been no change in Ramsay Health Care’s business activities and the outlook also remains unchanged. Further, the fundamentals of the private hospital industry remain unchanged. In particular, demand for hospital services is expected to have strong long term growth due to the aging population. Additionally, governments are fiscally constrained which is likely to limit public investment in hospitals and advancements in medical technology is opening new opportunities for medical treatment in hospitals.




This article has been prepared by the Australian Stock Report Pty Ltd (AFSL: 301 682. ABN: 94 106 863 978)

(“ASR”). ASR is part of Amalgamated Australian Investment Group Limited (AAIG) (ABN: 81 140 208 288 Level 13, 130 Pitt Street, Sydney NSW 2000).

This article is provided for informational purpose only and does not purport to contain all matters relevant to any particular investment or financial instrument. Any market commentary in this communication is not intended to constitute “research” as defined by applicable regulations. Whilst information published on or accessed via this website is believed to be reliable, as far as permitted by law we make no representations as to its ongoing availability, accuracy or completeness. Any quotes or prices used herein are current at the time of preparation. This document and its contents are proprietary information and products of our firm and may not be reproduced or otherwise disseminated in whole or in part without our written consent unless required to by judicial or administrative proceeding. The ultimate decision to proceed with any transaction rests solely with you. We are not acting as your advisor in relation to any information contained herein. Any projections are estimates only and may not be realised in the future.

ASR has no position in any of the stocks mentioned.

New call-to-action